The Rudd Report Publishes Updated Research on Industrial Biotechnology Corporation (IBTY) Monday July 24, 11:50 am ET
Industrial Biotechnology Corporation (OTC Pink Sheets: IBTY - News; IBC), a company dedicated to new biotechnologies and innovations in the chemical industry, today announced The Rudd Report, an independent research firm and division of Savannah Capital Management, has updated their coverage on Industrial Biotechnology with a high risk "buy" recommendation and 18 month target price of $6.00. (Logo: http://www.newscom.com/cgi-bin/prnh/20060629/FLTH021LOGO ) Lauren Rudd is the publisher of The Rudd Report and President of Savannah Capital Management, a money management firm that is responsible for investment returns that have exceeded the performance of the S&P 500 Index every year since the company's inception. Lauren Rudd has over three decades of experience in business and financial research, investment analysis and professional writing with such firms as Legg Mason and Ferris Baker Watts and was a Business and Technology Consultant for AT&T. He currently writes six newspaper columns per week about Wall Street with an estimated readership of approximately 6 million readers. His report on Industrial Biotechnology Corporation includes a comprehensive look at the company's technology, growth prospects, market potential, competition and financials. A full copy of the fee- based research report is available at http://www.ruddreport.com/industrial_bio_tech.htm . About Industrial Biotechnology Corporation Industrial Biotechnology Corporation (IBC) commercializes proprietary technologies and intellectual property in the emerging field of biologically produced chemicals. We believe these technologies enable IBC to more efficiently manufacture high-value chemicals at significantly lower costs, with a higher purity and with a substantially lower environmental impact than traditional methods. Through licensing, partnerships, and direct sales via multiple distribution channels to several industries, IBC seeks to bring to market new and established chemicals that are in high demand for use in the flavors and fragrances, fine chemicals, pharmaceuticals, cosmeceuticals, agricultural, biopesticides, bio- energy, biomaterials and biopolymer industries. IBC's pioneering and state-of-the-art biological production methods can replace large manufacturing facilities, many of which employ hazardous processes and toxic materials in their chemical production. These innovative methods involve fewer production steps, and through the use of "designer" enzymes and proprietary production systems, may enable IBC to produce greater yields of high-purity, natural compounds at significantly lower costs. We believe these processes can be readily scaled up to large commercial production levels. The company has assembled a team of leading scientists, management and industry leaders to implement these new technologies. IBC has a comprehensive technology and licensing acquisition strategy, and seeks to establish research and development partnerships with leading universities and corporations in the industrial biotechnology field to develop commercially viable, biological-based solutions and related intellectual property patents. For more information about Industrial Biotechnology Corporation, please visit its website at http://www.industrialbiotechnology.com . Forward-Looking Statements Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words such as "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe Industrial Biotechnology Corporation's future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of Industrial Biotechnology Corporation, as appropriate, which could cause actual results to differ materially from those currently anticipated. Although Industrial Biotechnology Corporation believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, they cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. These forward-looking statements are only made as of the date of this press release and Industrial Biotechnology Corporation does not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. The Rudd Report has previously received from Industrial Biotechnology 300,000 shares of restricted stock for a full year of coverage that includes initiation and update reports. For complete details, refer to the disclaimer details in each report. Contact: Industrial Biotechnology Corporation Jack Hensley Vice President, Public & Investor Relations 2033 Main Street Sarasota, FL 34237 941-925-2500 [EMAIL PROTECTED] --------------------------------------------------------------------- ----------- Source: Industrial Biotechnology Corporation ------------------------ Yahoo! Groups Sponsor --------------------~--> Yahoo! Groups gets a make over. See the new email design. http://us.click.yahoo.com/WktRrD/lOaOAA/yQLSAA/H4xqlB/TM --------------------------------------------------------------------~-> http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
